Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
DMK PHARMACEUTICALS Corp has filed 1,210 SEC EDGAR filings since 13 Feb 1996

SEC filing history

Showing 276-300 of 775 matching filings.

Per page
25
Current page
12
4

PRIMARY DOCUMENT

Filing date
26 Feb 2020
Reporting date
24 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
26 Feb 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-226100

PROSPECTUS

Filing date
24 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
21 Feb 2020
Reporting date
21 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45279

DECEMBER 31, 2019

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
13 Feb 2020
Reporting date
26 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-45279

DECEMBER 31, 2019

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45279

SC 13G/A

Filing date
10 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45279

NONE

Filing date
04 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
26 Dec 2019
Reporting date
19 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
25 Nov 2019
Reporting date
25 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
12 Nov 2019
Reporting date
12 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36242

QUARTERLY REPORT

Filing date
12 Nov 2019
Reporting date
30 Sep 2019
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
16 Oct 2019
Reporting date
15 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
15 Oct 2019
Reporting date
11 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Oct 2019
Reporting date
26 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Oct 2019
Reporting date
26 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Oct 2019
Reporting date
26 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
10 Oct 2019
Reporting date
04 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
04 Oct 2019
Reporting date
30 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .